Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BIO 017

Next Previous
Drug Profile

BIO 017

Alternative Names: BIO-017

Latest Information Update: 27 Sep 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Biom Therapeutics
  • Class Antiepileptic drugs; Cannabinoids
  • Mechanism of Action G-protein-coupled receptor 55 modulators; TRPV1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Angelman syndrome
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Epilepsy
  • Phase I Angelman syndrome

Most Recent Events

  • 27 Sep 2023 Phase-I clinical trials in Angelman syndrome in an unknown location (Unspecified route) (Biom Therapeutics pipeline, September 2023)
  • 27 Apr 2021 BIO 017 is available for licensing as of 27 Apr 2021. https://biomtherapeutics.com/rd/
  • 27 Apr 2021 Biom Therapeutics has patents pending for improved cannabinoid delivery via nano-emulsion technology (Biom Therapeutics website, April 2021).

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top